Mr. Speaker, may I rise on a question of privilege. This arises as a result of something which came to my attention late last evening. During the debate on Bill No. C-190 on February 12 as reported at page 6851 of Hansard I stated that chloramphenicol manufactured in the United States by nine companies had been allowed back on the market after rechecking. My information, Mr. Speaker, was incorrect. These products have not been allowed back on the United States market. I apologize to the house and express my appreciation in particular to the hon. member for Simcoe East (Mr. Rynard) and the hon. member for Queens (Mr. MacLean) for drawing this matter to my attention.